This plant-derived compound is just one of many that have been shown to have anti-cancer properties.
And though here exist no human trials involving Resveratrol to date, scientists do see promise based on the early research.
- Active Clinical Trials
Ensuring a high-quality manufactured brand is important for any supplement, so here's the brand recommended by Dr. Heather Wright, ND, FABNO:
None currently available
Title: The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
Summary: This study, from January 2020, reviews all the research regarding Resveratrol and brain cancer to date and finds promising results that warrant further study.
- Resveratrol exhibits a number of tumor-inhibiting properties
- It alleviates tumor resistance to Temodar
- It crosses the blood-brain barrier
Title: Focus on the Use of Resveratrol as an Adjuvant in Glioblastoma Therapy
Summary: This study, also from 2020, reviews the data on Resveratrol to date and also finds there are promising opportunities for Resveratrol in the treatment of brain cancer.
- It does reach the tumor environment
- There is pre-clinical evidence it has efficacy to treat brain cancer
Title: Resveratrol and siRNA in combination reduces Hsp27 expression and induces caspase-3 activity in human glioblastoma cells
Summary: This study tested the ability of Resveratrol to counteract an important protein of cancer cells that enables them resistance to Chemotherapy and found it does indeed counteract the protein.
- Resveratrol has potential as a treatment for brain cancer